The reliability and prognosis of in-hospital diagnosis of metabolic syndrome in the setting of acute myocardial infarction

Journal of the American College of Cardiology

Volumn 62, Issue 8, 2013, Pages 704-708

  Arnold, Suzanne V ^a,b   Lipska, Kasia J ^c   Li, Yan ^a   Goyal, Abhinav ^d   Maddox, Thomas M ^e   McGuire, Darren K ^f   Spertus, John A ^a,b   Kosiborod, Mikhail ^a,b  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

long term outcomes metabolic syndrome myocardial infarction

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT IDENTIFICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

ACUTE MYOCARDIAL INFARCTION; AMI; CAD; CORONARY ARTERY DISEASE; LONG-TERM OUTCOMES; METABOLIC SYNDROME; METS; MYOCARDIAL INFARCTION;

FEMALE; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY, ABDOMINAL; PROGNOSIS; REGISTRIES; RISK FACTORS; UNITED STATES;

EID: 84883433810     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.02.062     Document Type: Article

References (10)

1. C.A. Daly, P. Hildebrandt, and M. Bertrand Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial Heart 93 2007 1406 1411
2. G.C. Fonarow, A. Gawlinski, S. Moughrabi, and J.H. Tillisch Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP) Am J Cardiol 87 2001 819 822
3. J.M. Lappe, J.B. Muhlestein, and D.L. Lappe Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program Ann Intern Med 141 2004 446 453
4. S.V. Arnold, P.S. Chan, and P.G. Jones Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH): design and rationale of a prospective multicenter registry Circ Cardiovasc Qual Outcomes 4 2011 467 476
5. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
6. K.A. Eagle, M.J. Lim, and O.H. Dabbous A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry JAMA 291 2004 2727 2733
7. J.M. Dekker, C. Girman, and T. Rhodes Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn study Circulation 112 2005 666 673
8. H.M. Lakka, D.E. Laaksonen, and T.A. Lakka The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men JAMA 288 2002 2709 2716
9. E.S. Ford, W.H. Giles, and A.H. Mokdad Increasing prevalence of the metabolic syndrome among U.S. adults Diabetes Care 27 2004 2444 2449
10. J.L. Petersen, E. Yow, and W. AlJaroudi Metabolic syndrome is not associated with increased mortality or cardiovascular risk in nondiabetic patients with a new diagnosis of coronary artery disease Circ Cardiovasc Qual Outcomes 3 2010 165 172